Home Healthcare Healthcare IT Computer-Aided Detection Market

Computer-Aided Detection Market Size, Share & Trends Analysis Report By Technology (Deep Learning-Based, Machine Learning-Based, Traditional CAD Systems,, Hybrid Models, Others), By Application (Tuberculosis, Breast cancer, Lung cancer, Colon/rectal cancer, Prostate cancer, Liver cancer, Bone cancer, Others (Neurological/musculoskeletal/cardiovascular Indications)), By Indication (X-ray imaging, Computed tomography, Ultrasound imaging, Magnetic resonance imaging, Nuclear medicine imaging, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 22, 2026 | Author: Dhanashri B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Computer-Aided Detection Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Deep Learning-Based
    2. Machine Learning-Based
    3. Traditional CAD Systems,
    4. Hybrid Models
    5. Others
  2. Computer-Aided Detection Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Tuberculosis
    2. Breast cancer
    3. Lung cancer
    4. Colon/rectal cancer
    5. Prostate cancer
    6. Liver cancer
    7. Bone cancer
    8. Others (Neurological/musculoskeletal/cardiovascular Indications)
  3. Computer-Aided Detection Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. X-ray imaging
    2. Computed tomography
    3. Ultrasound imaging
    4. Magnetic resonance imaging
    5. Nuclear medicine imaging
    6. Others
  4. Regional Computer-Aided Detection Market
    1. North America
      1. North America Computer-Aided Detection Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
      2. North America Computer-Aided Detection Market By Application 2022-2034 (USD MILLION/ Units)
        1. Tuberculosis
        2. Breast cancer
        3. Lung cancer
        4. Colon/rectal cancer
        5. Prostate cancer
        6. Liver cancer
        7. Bone cancer
        8. Others (Neurological/musculoskeletal/cardiovascular Indications)
      3. North America Computer-Aided Detection Market By Indication 2022-2034 (USD MILLION/ Units)
        1. X-ray imaging
        2. Computed tomography
        3. Ultrasound imaging
        4. Magnetic resonance imaging
        5. Nuclear medicine imaging
        6. Others
      4. U.S.
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      5. Canada
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
    2. Europe
      1. Europe Computer-Aided Detection Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
      2. Europe Computer-Aided Detection Market By Application 2022-2034 (USD MILLION/ Units)
        1. Tuberculosis
        2. Breast cancer
        3. Lung cancer
        4. Colon/rectal cancer
        5. Prostate cancer
        6. Liver cancer
        7. Bone cancer
        8. Others (Neurological/musculoskeletal/cardiovascular Indications)
      3. Europe Computer-Aided Detection Market By Indication 2022-2034 (USD MILLION/ Units)
        1. X-ray imaging
        2. Computed tomography
        3. Ultrasound imaging
        4. Magnetic resonance imaging
        5. Nuclear medicine imaging
        6. Others
      4. U.K.
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      5. Germany
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      6. France
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      7. Spain
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      8. Italy
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      9. Russia
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      10. Nordic
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      11. Benelux
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      12. Rest of Europe
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
    3. APAC
      1. APAC Computer-Aided Detection Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
      2. APAC Computer-Aided Detection Market By Application 2022-2034 (USD MILLION/ Units)
        1. Tuberculosis
        2. Breast cancer
        3. Lung cancer
        4. Colon/rectal cancer
        5. Prostate cancer
        6. Liver cancer
        7. Bone cancer
        8. Others (Neurological/musculoskeletal/cardiovascular Indications)
      3. APAC Computer-Aided Detection Market By Indication 2022-2034 (USD MILLION/ Units)
        1. X-ray imaging
        2. Computed tomography
        3. Ultrasound imaging
        4. Magnetic resonance imaging
        5. Nuclear medicine imaging
        6. Others
      4. China
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      5. Korea
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      6. Japan
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      7. India
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      8. Australia
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      9. Taiwan
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      10. South East Asia
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      11. Rest of Asia-Pacific
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
    4. Middle East and Africa
      1. Middle East and Africa Computer-Aided Detection Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
      2. Middle East and Africa Computer-Aided Detection Market By Application 2022-2034 (USD MILLION/ Units)
        1. Tuberculosis
        2. Breast cancer
        3. Lung cancer
        4. Colon/rectal cancer
        5. Prostate cancer
        6. Liver cancer
        7. Bone cancer
        8. Others (Neurological/musculoskeletal/cardiovascular Indications)
      3. Middle East and Africa Computer-Aided Detection Market By Indication 2022-2034 (USD MILLION/ Units)
        1. X-ray imaging
        2. Computed tomography
        3. Ultrasound imaging
        4. Magnetic resonance imaging
        5. Nuclear medicine imaging
        6. Others
      4. UAE
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      5. Turkey
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      6. Saudi Arabia
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      7. South Africa
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      8. Egypt
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      9. Nigeria
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      10. Rest of MEA
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
    5. LATAM
      1. LATAM Computer-Aided Detection Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
      2. LATAM Computer-Aided Detection Market By Application 2022-2034 (USD MILLION/ Units)
        1. Tuberculosis
        2. Breast cancer
        3. Lung cancer
        4. Colon/rectal cancer
        5. Prostate cancer
        6. Liver cancer
        7. Bone cancer
        8. Others (Neurological/musculoskeletal/cardiovascular Indications)
      3. LATAM Computer-Aided Detection Market By Indication 2022-2034 (USD MILLION/ Units)
        1. X-ray imaging
        2. Computed tomography
        3. Ultrasound imaging
        4. Magnetic resonance imaging
        5. Nuclear medicine imaging
        6. Others
      4. Brazil
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      5. Mexico
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      6. Argentina
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      7. Chile
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      8. Colombia
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
      9. Rest of LATAM
        1. Deep Learning-Based
        2. Machine Learning-Based
        3. Traditional CAD Systems,
        4. Hybrid Models
        5. Others
        6. Tuberculosis
        7. Breast cancer
        8. Lung cancer
        9. Colon/rectal cancer
        10. Prostate cancer
        11. Liver cancer
        12. Bone cancer
        13. Others (Neurological/musculoskeletal/cardiovascular Indications)
        14. X-ray imaging
        15. Computed tomography
        16. Ultrasound imaging
        17. Magnetic resonance imaging
        18. Nuclear medicine imaging
        19. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.